As the enzyme is highly expressed in mineralocorticoid target tissues, its glucocorticoid inactivation function prevents cortisol occupying the mineralocorticoid receptor (MR) which may lead to sodium retention, hypokalemia and hypertension.4,5. The gene discussed is NR3C2; the disease is hypertensive disorder.